New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2014
05:41 EDTAMAGAMAG Pharmaceuticals upgraded to Hold from Underperform at Jefferies
Jefferies upgraded AMAG Pharmaceuticals to Hold citing limited downside potential after the FDA issued a complete response letter for Feraheme broader use. The firm raised its price target for shares to $19 from $16.
News For AMAG From The Last 14 Days
Check below for free stories on AMAG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
07:17 EDTAMAGLumara Health to be acquired in two separate transactions for $1.11B
Subscribe for More Information
07:16 EDTAMAGAMAG Pharmaceuticals to host conference call
Conference call to discuss a definitive agreement to acquire Lumara Health Inc will be held at 8 am on September 29. Webcast Link
06:59 EDTAMAGAMAG Pharmaceuticals to acquire Lumara Health for $675M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use